Health economic impact of Nerinetide in addition to mechanical thrombectomy without concurrent alteplase

CONCLUSION: Treating patients with a cerebroprotectant, such as Nerinetide, in addition to endovascular treatmentl in patients who cannot receive intravenous alteplase may be beneficial from a health-economic standpoint.PMID:37590087 | DOI:10.1177/15910199231193455

Source: Interventional Neuroradiology - August 17, 2023 Category: Radiology Authors: Johanna M Ospel Corey Adams Michael Tymianski Mayank Goyal Michael Hill Source Type: research